CXCR 1 and 2 receptor antagonist (Anchor Therapeutics)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCXCR 1 and 2 receptor antagonist (Anchor Therapeutics)
Drug Alias NameCXCR 1 and 2 receptor antagonist (Ascent Therapeutics)pepducins (Ascent Therapeutics)pepducins (Anchor Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-X-C motif chemokine receptor 2 antagonistsC-X-C motif chemokine receptor 1 antagonistsInterleukin-8 inhibitors
TargetsC-X-C motif chemokine receptor 1C-X-C motif chemokine receptor 2Interleukin-8
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnchor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnchor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A